AACT for ALS

The AACT for ALS was signed into law in by President Biden on December 2021.

The bill was among the most cosponsored bills in the last half century. Congress just appropriated money for FY 2022. But people with ALS don’t yet have access.

Now what?

How does the FDA’s Expanded Access Program work?
How do people with ALS get Expanded Access to Investigational Drugs?
What drugs will qualify for EAPs?
What clinics can apply?
What do drug sponsors need to do?
What costs are covered?

The webinar is hosted by the Gleason Institute at Washington State University.